Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04673994 · ClinicalTrials.gov registry record
Blood Flow Response and Acute INterval Exercise
A clinical trial, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- 91
- Enrollment target
NCT04673994: Completed study, sponsored by University of Kansas Medical Center.
NCT04673994 is a clinical trial that has completed, run by University of Kansas Medical Center. The registered enrollment target is 91 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04673994 has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- 91 participants
- Enrollment target
Study Summary
The objective of this project is to study the cerebrovascular response to a single bout of high intensity interval exercise (HIIT) in 25 individuals with chronic stroke compared to 25 age- and sex- matched healthy controls (CON). We will enroll 25 young healthy adults (CONyoung) as a reference group. Our hypothesis is that the cerebrovascular response in individuals with chronic stroke will be significantly lower: 1) during a single bout of HIIT, and 2) during the recovery immediately following and 30 minutes after HIIT, compared to CON. This study has 2 visits at the University of Kansas Medical Center Research in Exercise and Cardiovascular Health Laboratory. For the first visit, we will perform questionnaires about heart health, physical activity and overall health. Participants will then complete a submaximal exercise test on a seated stepper. Participants will also have a familiarization session to practice HIIT. The second visit will include cerebrovascular measures before, during, immediately after, and 30 minutes after performing HIIT.
Primary Outcome
blood velocity traveling through the middle cerebral artery measured using the transcranial Doppler ultrasound.
Interventions
- BEHAVIORAL Single, acute bout of high intensity interval exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2020-12-09 |
| Est. Completion | 2023-02-03 |
What the finished NCT04673994 record still lists
NCT04673994 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 91 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Single, acute bout of high intensity interval exercise is the first listed.
NCT04673994 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04673994 about?
NCT04673994 is a clinical study titled "Blood Flow Response and Acute INterval Exercise". The objective of this project is to study the cerebrovascular response to a single bout of high intensity interval exercise (HIIT) in 25 individuals with chronic stroke compared to 25 age- and sex- matched healthy controls (CON). We will enroll 25 young healthy adults (CONyoung) as a reference group...
What is the current status of trial NCT04673994?
This trial is currently completed. The enrollment target is 91 participants. The study started on 2020-12-09. Estimated completion is 2023-02-03.
What interventions are being tested in trial NCT04673994?
The interventions under investigation include: Single, acute bout of high intensity interval exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT04673994?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI